Connect with us

INDIA

Covid-19 reinfection ‘very rare’ occurrence, not a matter of concern: ICMR DG

Published

on

covid-19-reinfection-‘very-rare’-occurrence,-not-a-matter-of-concern:-icmr-dg

NEW DELHI: Coronavirus reinfection is possible even though it is a “very rare” occurrence, ICMR DG Balram Bhargava said on Tuesday and stressed that it is not a matter of serious concern.

The remarks come amid suspected cases of Covid-19 reinfection being reported from abroad and from Indian states like Telangana, Karnataka, Gujarat, Punjab and Maharashtra.

Responding to a question on the issue, Bhargava told a press conference that reinfection was “very, very rare” with Covid-19, but it can happen as had been seen in a case in Hong Kong.

“We have seen that someone gets measles and he is supposed to be protected all his life because he generates certain antibodies, but then we have seen reinfection occurring in measles.

“Similarly, we can have reinfection with Covid-19 as has been described by the case in Hong Kong and it is not a matter of serious concern,” Bhargava said.

In an earlier press conference, he had said that there was a need to find out how long the immunity lasts against the infection.

On coronavirus vaccine development, the ICMR director general said three vaccines are at clinical trial stages in the country and two indigenously ones developed by Cadila and Bharat Biotech have completed phase-I trial.

The results are being analysed and they have completed recruitment for the second phase, he said.

Serum Institute of India has completed phase II-B3 trials of the Oxford COVID-19 vaccine candidate. There was a pause of seven days. They will start the phase-III trial with 1,500 patients at 14 locations in India after clearances, Bhargava said.

The Drugs Controller General of India (DCGI) had directed Serum Institute of India to suspend any new recruitment in the phase-II and III clinical trial of the Oxford COVID-19 vaccine candidate till further orders in the backdrop of pharma giant AstraZeneca pausing the clinical trials in other countries.

Speaking about the vaccine developed in Russia, the ICMR DG said their first study of 76 patients has been published in the journal Lancet, which is “showing good effectiveness and immune-antibody generation”. He said Russia has not yet completed Phase-III trial.

Dialogues are going on between the High-Level Committee on Vaccines and the Russian diplomats about the mechanisms for conducting Phase-III trial in India, he said.

British-Swedish biopharmaceutical giant AstraZeneca and the University of Oxford had on Saturday said that clinical trials for their coronavirus vaccine have resumed in the United Kingdom after Medicines and Healthcare products Regulatory Agency (MHRA) confirmed that the trials were safe.

The human trials resumed days after a pause had been announced in the trials after an adverse reaction in one of the participants.

Addressing a query on the national sero-survey, Bhargava said the survey, which was done in April-May and is being repeated after three months, has been completed in 68 out of 70 districts. After analysis of the results by this month end, the two studies can be compared, he said.

The senior official added that the sero-survey also brings out infection fatality rate, which was found to be between 0.5-0.6 in the last national sero-survey, which was much below than in many other countries.

The Times of India is an Indian English-language daily newspaper owned by The Times Group. It is the third-largest newspaper in India by circulation and largest selling English-language daily in the world. according to Audit Bureau of Circulations.

Continue Reading
Click to comment

INDIA

Govt will need 80,000 crore for Covid vaccine, says Serum CEO

Published

on

govt-will-need-80,000-crore-for-covid-vaccine,-says-serum-ceo

MUMBAI: The government may need Rs 80,000 crore over the next one year for distribution of Covid-19 vaccine and immunization of the country’s population, Adar Poonawalla, CEO and promoter of the world’s largest vaccine producer, Serum Institute, said on Saturday.

Calling it the “next concerning challenge”, which needs to be tackled, Poonawalla posted a tweet tagging the Prime Minister’s Office, which read: “We need to plan and guide vaccine manufacturers both in India and overseas to service the needs of our country in terms of procurement and distribution.”

Serum has tie ups with global manufacturers AstraZeneca and Novavax for potential Covid-19 vaccines, which are currently undergoing clinical trials. The tweet, perceived by many as alarming, also raised concerns over the government’s ability to fund the massive vaccine programme.

“The government has assured that there will be plenty of funds available for vaccines. We have now been assured by the highest levels in the government that enough funds will be available for vaccine procurement, supply and logistics. This is good news,” Poonawalla told TOI, when contacted.

While addressing the United Nations General Assembly on Saturday PM Modi said that as the world’s largest vaccine producing country, India’s vaccine production and delivery capacity will be used to help people across the world.

Although further details on Poonawala’s calculations were not immediately available, sources said, it could be assuming the benchmark price of $3-5 per dose, and including two doses for the over 1.3 billion population.

Continue Reading

INDIA

Congress may rope in Prashant Kishor for 2022 Punjab election

Published

on

congress-may-rope-in-prashant-kishor-for-2022-punjab-election

NEW DELHI: Pollster Prashant Kishor may get to manage Congress in the Punjab elections scheduled for early 2022. Party sources said CM Amarinder Singh is in talks with the former JD(U) member and election strategist, and a decision may be announced soon.

While Kishor is likely to get the contract for advance poll planning in the state, Congress members said he could even get an official perch to manage the affairs. Kishor had widely been credited with helping Congress ride back to power in the state in 2017. A senior AICC manager said the talks are being held by the chief minister and that the party is not involved in the negotiations.

While speculations about Kishor coming on board the Congress campaign in Punjab have been on for a while, it is only now it appears to be reaching a finality. Having been expelled from JD(U) following a scrap with Bihar CM Nitish Kumar, Kishor is said to be on the lookout for a new political platform – a reason why there are also speculations that he is looking for an entry in Congress.

Well-placed sources in Congress said Kishor has a direct line with the Gandhi siblings, a reason why not many are willing to hazard a guess about the pollster. There is some confusion in Congress ranks about Kishor.

Sources said a possible reason for CM Singh to get Kishor on board in Punjab would be to ensure that he does not work for Arvind Kejriwal’s AAP, which is set to make a strong pitch in the state in the next polls.

Continue Reading

INDIA

India slams Pakistan PM at UNGA for terror export

Published

on

india-slams-pakistan-pm-at-unga-for-terror-export

NEW DELHI: After Pakistan PM Imran Khan again raised the Kashmir issue at UNGA, India slammed Pakistan saying terrorism was its only crowning glory. Exercising its Right of Reply, the Indian mission also accused Khan of warmongering and of using the multilateral forum to spread lies, misinformation and malice.

“This august forum witnessed a new low on its 75th anniversary. The leader of Pakistan today called for those who incite hate and violence to be outlawed. But as he went on, we were left wondering, was he referring to himself?” said Mijito Vinito, the first secretary in the permanent mission of India to the UN, Mijito Vinito, exercising India’s Right of Reply.

The only crowning glory, he said, that this country has to show to the world for the last 70 years is terrorism, ethnic cleansing, majoritarian fundamentalism and clandestine nuclear trade. “This hall heard the incessant rant of someone who had nothing to show for himself, who had no achievements to speak of and no reasonable suggestion to offer to the world. Instead, we saw lies, misinformation, war mongering and malice spread through this Assembly,” he added.

Pakistan later exercised its right of reply too, in which it claimed that Jammu & Kashmir was never a part of India. Alluding to the “stellar record” of Pakistan, Vinito said this is the country that has the “dubious distinction” of hosting the largest number of terrorists proscribed by the United Nations, a reference to terror masterminds such as Lashkar-e-Taiba (LeT) founder Hafiz Saeed and Jaish-e-Mohammed (JeM) head Masood Azhar.

“This is the same country that provides pensions for dreaded and listed terrorists out of state funds. The leader whom we heard today is the same person who referred to terrorist Osama Bin Laden as a ‘martyr’ in the Pakistani Parliament in July,” Vinito said.

He added that it is Pakistan that brought genocide to south Asia 39 years ago when it killed its own people and it is also the country that is “shameless enough” not to offer a sincere apology for the horrors it perpetratedeven after so many years. India asserted in its Right of Reply that Khan, “who spewed venom today”, admitted in 2019 in public in the US that his country still has about 30,000-40,000 terrorists, who have been trained by Pakistan and have fought in Afghanistan and in the Indian Union Territory of Jammu and Kashmir.

“This is the country that has systematically cleansed its minorities , including Hindus, Christians, Sikhs and others, through the abuse of its blasphemy laws and through forced religious conversions,” Vinito said.

Continue Reading

Trending Facebook

You May Like

Black Lives Matter

Trending

Enable Notifications    Ok No thanks